ASTRO: Liquid Biopsy Can Stratify Risk in Oligometastatic NS

Liquid biopsy, which identifies circulating tumor DNA (ctDNA), performed before radiotherapy (RT) can stratify risk for oligometastatic non-small cell lung cancer (NSCLC) patients.

Related Keywords

San Diego , California , United States , American , Nicholasp Semenkovich , Aadel Chaudhuri , Washington University , Washington University School Of Medicine , American Society For Radiation Oncology , Healthday News , Precision Oncology , American Society , Radiation Oncology , Washington University School ,